These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 8382553

  • 1. Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.
    Tsai CM, Hsiao SH, Frey CM, Chang KT, Perng RP, Gazdar AF, Kramer BS.
    Cancer Res; 1993 Mar 01; 53(5):1079-84. PubMed ID: 8382553
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors.
    Kogure T, Ueno Y, Iwasaki T, Shimosegawa T.
    Cancer Chemother Pharmacol; 2004 Apr 01; 53(4):296-304. PubMed ID: 14689231
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
    Mini E, Moroson BA, Bertino JR.
    Cancer Treat Rep; 1987 Apr 01; 71(4):381-9. PubMed ID: 2950995
    [Abstract] [Full Text] [Related]

  • 4. A study of various strategies to enhance the cytotoxic activity of 5-fluorouracil/leucovorin in human colorectal cancer cell lines.
    Scheithauer W, Temsch EM.
    Anticancer Res; 1989 Apr 01; 9(6):1793-8. PubMed ID: 2627128
    [Abstract] [Full Text] [Related]

  • 5. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug 01; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 6. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
    Bjelogrlić SK, Srdić T, Radulović S.
    J BUON; 2007 Aug 01; 12(1):71-6. PubMed ID: 17436405
    [Abstract] [Full Text] [Related]

  • 7. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL, Hwang J, Perng RP, Whang-Peng J.
    Oncol Res; 1995 Aug 01; 7(1):31-8. PubMed ID: 7549042
    [Abstract] [Full Text] [Related]

  • 8. [Experimental study of biochemical modulation of 5-fluorouracil with l-leucovorin against human esophageal cancer].
    Terashima M, Ikeda K, Kawamura H, Maesawa C, Takiyama I, Yoshinari H, Koeda K, Sato N, Ishida K, Saito K.
    Gan To Kagaku Ryoho; 1992 Oct 01; 19(12):1999-2004. PubMed ID: 1417007
    [Abstract] [Full Text] [Related]

  • 9. [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil].
    Yuasa C, Okabe H, Toko T, Takeda S, Unemi N.
    Gan To Kagaku Ryoho; 1995 Nov 01; 22(13):1927-32. PubMed ID: 7487122
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammineglycolatoplatinum (254-S) and cis-diamminedichloroplatinum.
    Koenuma M, Kasai H, Uchida N, Wada T, Hattori M, Oguma T, Totani T, Inaba M.
    Anticancer Res; 1995 Nov 01; 15(2):417-21. PubMed ID: 7763015
    [Abstract] [Full Text] [Related]

  • 11. [Cytotoxic effects of the combination of a new nitrosourea, fotemustine, combined with 5-fluorouracil and folinic acid depend on the sequence of their administration].
    Fischel JL, Formento P, Berlion M, Berille J, Gioanni J, Bizzari JP, Milano G.
    Bull Cancer; 1992 Nov 01; 79(1):81-90. PubMed ID: 1520955
    [Abstract] [Full Text] [Related]

  • 12. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
    Matsumoto S, Igishi T, Hashimoto K, Kodani M, Shigeoka Y, Nakanishi H, Touge H, Kurai J, Makino H, Takeda K, Yasuda K, Hitsuda Y, Shimizu E.
    Int J Oncol; 2004 Nov 01; 25(5):1311-8. PubMed ID: 15492820
    [Abstract] [Full Text] [Related]

  • 13. [Comparison between leucovorin and cisplatin as a modulator of 5-fluorouracil].
    Iba T, Yagi Y, Kidokoro A, Fukunaga T.
    Gan To Kagaku Ryoho; 1993 Mar 01; 20(4):479-83. PubMed ID: 8452385
    [Abstract] [Full Text] [Related]

  • 14. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells.
    Tillman DM, Petak I, Houghton JA.
    Clin Cancer Res; 1999 Feb 01; 5(2):425-30. PubMed ID: 10037193
    [Abstract] [Full Text] [Related]

  • 15. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.
    Moran RG, Scanlon KL.
    Cancer Res; 1991 Sep 01; 51(17):4618-23. PubMed ID: 1831402
    [Abstract] [Full Text] [Related]

  • 16. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
    Esaki T, Nakano S, Tatsumoto T, Kuroki-Migita M, Mitsugi K, Nakamura M, Niho Y.
    Cancer Res; 1992 Dec 01; 52(23):6501-6. PubMed ID: 1423296
    [Abstract] [Full Text] [Related]

  • 17. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
    Petak I, Tillman DM, Houghton JA.
    Clin Cancer Res; 2000 Nov 01; 6(11):4432-41. PubMed ID: 11106264
    [Abstract] [Full Text] [Related]

  • 18. Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines.
    Bando T, Fujimura M, Kasahara K, Matsuda T.
    Anticancer Res; 1998 Nov 01; 18(2A):1085-9. PubMed ID: 9615770
    [Abstract] [Full Text] [Related]

  • 19. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M, Benzo A, Irrissuto C, Lopez G, Curatella B, Maggi CA, Manzini S, Crea A, Caroli S, Cubadda F, Binaschi M.
    Cancer Chemother Pharmacol; 2008 Sep 01; 62(4):621-9. PubMed ID: 18038274
    [Abstract] [Full Text] [Related]

  • 20. Lack of in vitro synergy between etoposide and cis-diamminedichloroplatinum(II).
    Tsai CM, Gazdar AF, Venzon DJ, Steinberg SM, Dedrick RL, Mulshine JL, Kramer BS.
    Cancer Res; 1989 May 01; 49(9):2390-7. PubMed ID: 2706626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.